Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207989> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W4387207989 endingPage "S46" @default.
- W4387207989 startingPage "S46" @default.
- W4387207989 abstract "The aim is to report toxicity and cosmetic outcomes at 3 and up to 9 years of follow-up of post-menopausal patients randomized to receive either standard whole breast irradiation (WBI), including hypofractionated options, versus accelerated partial breast irradiation (APBI).From December 2010 to July 2015, 1006 patients were enrolled in 34 French centers. Among the whole population, 28 patients who did not meet the final selection criteria or withdrew consent were excluded leading to a modified intention to treat analysis dataset of 978 patients (WBI: n = 488; APBI: n = 490). Median age (65y) and tumor stage pT1 (99%) rates were similar in both arms. Patients had conservative surgery with clip placement in the tumor bed. Clear margins (> 2mm) were observed in 99% of the patients. In both arms, 96-97% of the patients had negative sentinel lymph node biopsy. The median time interval between surgery and radiotherapy was 57d in WBI vs 62d in APBI. WBI schedules consisted of 50 Gy in 25 fr+16 Gy (n = 212) or 40 Gy in 15 fr (n = 156) or 42.5 Gy in 16 fr (n = 120). APBI arm consisted of 38.5 Gy or 40 Gy in 10 fr, 2 fr/day. Overall, 94 patients from the APBI arm finally received standard WBI. For statistical considerations, SHARE trial, sponsored by UNICANCER (NCT01247233) is a non-inferiority randomized controlled trial comparing APBI versus WBI in terms of local control as primary objective. Secondary endpoints were severe toxicity (NCI-CTCAE v4 grade ≥ 2), and cosmetic results. For both outcomes, we estimated the cumulative incidences (CI) using Kalbfleish and Prentice method, considering disease relapse, secondary cancer or death as competing events. Treatment effect (APBI vs WBI) was estimated by cause-specific Hazard Ratios (cs-HR) from Cox models.Median follow-up was 5.8y (range, 0.13-9.5). The number of deaths was 27, and the number of local relapses was 8. Among the 978 patients, 582 and 396 had finally WBI and APBI, respectively. The rates of post-operative hematoma, edema and infection were low: 8-9%, 2%, 3-2%, respectively. When considering any type of severe toxicity, we observed a significant reduction rate in APBI compared to WBI: cs-HR = 0.73 (95% confidence interval: 0.61-0.88); p = 0.001, and 3-year CI of severe toxicity at 45% in WBI vs 36% in APBI arm. The difference was also in favor of APBI when considering breast skin toxicity alone: cs-HR = 0.55 (0.44-0.70), p<0.001 and 3-year CI at 36% in WBI vs 21% in APBI arm. Conversely, for breast other toxicities, WBI was found less toxic than APBI with a 3-year CI of 8% vs 15%, respectively. When considering cosmetic results, we observed no significant difference between the two arms in both evaluations by physicians and patients.Historically SHARE is the first APBI trial that included hypofractionated schedules in the standard arm. We report increased risk of severe toxicity and skin breast toxicity in standard arm as compared with APBI arm without any difference in terms of cosmetic results. Longer follow-up is needed." @default.
- W4387207989 created "2023-09-30" @default.
- W4387207989 creator A5000164596 @default.
- W4387207989 creator A5001628805 @default.
- W4387207989 creator A5004444944 @default.
- W4387207989 creator A5006422634 @default.
- W4387207989 creator A5010923467 @default.
- W4387207989 creator A5012808042 @default.
- W4387207989 creator A5018249256 @default.
- W4387207989 creator A5020593337 @default.
- W4387207989 creator A5021027808 @default.
- W4387207989 creator A5027340205 @default.
- W4387207989 creator A5029189327 @default.
- W4387207989 creator A5037801171 @default.
- W4387207989 creator A5066201418 @default.
- W4387207989 creator A5067469764 @default.
- W4387207989 creator A5067730699 @default.
- W4387207989 creator A5068451174 @default.
- W4387207989 creator A5073011726 @default.
- W4387207989 creator A5076536874 @default.
- W4387207989 creator A5077550775 @default.
- W4387207989 creator A5091693659 @default.
- W4387207989 date "2023-10-01" @default.
- W4387207989 modified "2023-10-18" @default.
- W4387207989 title "Early Results of the French Multicenter, Randomized SHARE Trial Comparing Whole Breast Irradiation vs. Accelerated Partial Breast Irradiation in Postmenopausal Women with Early-Stage Breast Cancer" @default.
- W4387207989 doi "https://doi.org/10.1016/j.ijrobp.2023.06.324" @default.
- W4387207989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784505" @default.
- W4387207989 hasPublicationYear "2023" @default.
- W4387207989 type Work @default.
- W4387207989 citedByCount "0" @default.
- W4387207989 crossrefType "journal-article" @default.
- W4387207989 hasAuthorship W4387207989A5000164596 @default.
- W4387207989 hasAuthorship W4387207989A5001628805 @default.
- W4387207989 hasAuthorship W4387207989A5004444944 @default.
- W4387207989 hasAuthorship W4387207989A5006422634 @default.
- W4387207989 hasAuthorship W4387207989A5010923467 @default.
- W4387207989 hasAuthorship W4387207989A5012808042 @default.
- W4387207989 hasAuthorship W4387207989A5018249256 @default.
- W4387207989 hasAuthorship W4387207989A5020593337 @default.
- W4387207989 hasAuthorship W4387207989A5021027808 @default.
- W4387207989 hasAuthorship W4387207989A5027340205 @default.
- W4387207989 hasAuthorship W4387207989A5029189327 @default.
- W4387207989 hasAuthorship W4387207989A5037801171 @default.
- W4387207989 hasAuthorship W4387207989A5066201418 @default.
- W4387207989 hasAuthorship W4387207989A5067469764 @default.
- W4387207989 hasAuthorship W4387207989A5067730699 @default.
- W4387207989 hasAuthorship W4387207989A5068451174 @default.
- W4387207989 hasAuthorship W4387207989A5073011726 @default.
- W4387207989 hasAuthorship W4387207989A5076536874 @default.
- W4387207989 hasAuthorship W4387207989A5077550775 @default.
- W4387207989 hasAuthorship W4387207989A5091693659 @default.
- W4387207989 hasConcept C121608353 @default.
- W4387207989 hasConcept C126322002 @default.
- W4387207989 hasConcept C141071460 @default.
- W4387207989 hasConcept C146357865 @default.
- W4387207989 hasConcept C151730666 @default.
- W4387207989 hasConcept C168563851 @default.
- W4387207989 hasConcept C2777757722 @default.
- W4387207989 hasConcept C2781467025 @default.
- W4387207989 hasConcept C2908647359 @default.
- W4387207989 hasConcept C509974204 @default.
- W4387207989 hasConcept C530470458 @default.
- W4387207989 hasConcept C71924100 @default.
- W4387207989 hasConcept C86803240 @default.
- W4387207989 hasConcept C99454951 @default.
- W4387207989 hasConceptScore W4387207989C121608353 @default.
- W4387207989 hasConceptScore W4387207989C126322002 @default.
- W4387207989 hasConceptScore W4387207989C141071460 @default.
- W4387207989 hasConceptScore W4387207989C146357865 @default.
- W4387207989 hasConceptScore W4387207989C151730666 @default.
- W4387207989 hasConceptScore W4387207989C168563851 @default.
- W4387207989 hasConceptScore W4387207989C2777757722 @default.
- W4387207989 hasConceptScore W4387207989C2781467025 @default.
- W4387207989 hasConceptScore W4387207989C2908647359 @default.
- W4387207989 hasConceptScore W4387207989C509974204 @default.
- W4387207989 hasConceptScore W4387207989C530470458 @default.
- W4387207989 hasConceptScore W4387207989C71924100 @default.
- W4387207989 hasConceptScore W4387207989C86803240 @default.
- W4387207989 hasConceptScore W4387207989C99454951 @default.
- W4387207989 hasIssue "2" @default.
- W4387207989 hasLocation W43872079891 @default.
- W4387207989 hasLocation W43872079892 @default.
- W4387207989 hasOpenAccess W4387207989 @default.
- W4387207989 hasPrimaryLocation W43872079891 @default.
- W4387207989 hasRelatedWork W2060905781 @default.
- W4387207989 hasRelatedWork W2073937368 @default.
- W4387207989 hasRelatedWork W2100071372 @default.
- W4387207989 hasRelatedWork W2106734666 @default.
- W4387207989 hasRelatedWork W2126696112 @default.
- W4387207989 hasRelatedWork W2466949046 @default.
- W4387207989 hasRelatedWork W2805685780 @default.
- W4387207989 hasRelatedWork W3028812190 @default.
- W4387207989 hasRelatedWork W3029766897 @default.
- W4387207989 hasRelatedWork W3032465624 @default.
- W4387207989 hasVolume "117" @default.
- W4387207989 isParatext "false" @default.
- W4387207989 isRetracted "false" @default.
- W4387207989 workType "article" @default.